Breaking News

New Test Measures Coronavirus Antibodies That Can Block Future Infections

Minnesota based Imanis Life Sciences announced on September 14, 2020, an upcoming presentation about the development and validation of IMMUNO-COV™, the first scalable, quantitative neutralizing antibody test for COVID-19. In contrast to other antibody tests, the IMMUNO-COV assay specifically measures antibodies in the blood that can block infection by the SARS-Co-V-2 coronavirus that causes COVID19.